First target $90, second target $100
Neckline at $90 is the zone to watch
case 1. break 101.71 call cut 101. exit 102.4 close gap case 2.waitiing thorw for comfirmming candle pattern.
The candles keep side way and flat due to the uncertainty whether or not FDA will approve a drug, Kyndrisa, If Kyndrisa is not approved, it will negatively impact BioMarin’s share price. However, if it is approved, Kyndrisa will result in high profits for the company. So wait and see.
A march 100/115 bull risk reversal could get you in at a retest of support at 100 or participate in the upside. All it costs is the margin
Dopo un trend discendente seguono due Spinning top, la seconda fora con l'ombra il massimo della prima.